Finland, Jan. 12 -- Finland based Gilead Sciences Finland Oy has secured contract from Pohjois-Pohjanmaan hyvinvointialue for Pharmaceutical products - Hepcludex (bulevirtide) -?selection of a pharmaceutical product for the period 142025-?31122025 for the pharmaceutical procurement ring of the welfare region of Northern Ostrobothnia. The value of the contract is worth 6400000 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....